Person: YAZAN, HAKAN
38 results
Search Results
Now showing 1 - 10 of 38
Publication kronik balgamlı öksürüğün nadir bir nedeni: kor triatum sinister ve akciğer arteriovenöz malformasyon birlikteliği(2018-09-27T00:00:00Z) Yazan, Hakan; Al Shadfan, Lina Muhammed; Yozgat, Yılmaz; Çakır, Erkan; YAZAN, HAKAN; YOZGAT, YILMAZ; ÇAKIR, ERKANPublication post enfeksiyöz bronşiolitis obliterans hastalarının klinik ve radyolojik olarak değerlendirilmesi(2019-04-11T00:00:00Z) ABDİLLAHİ, FATOUMA KHALİF; Al Shadfan, Lina; Bilgin, Mehmet; Yazan, Hakan; Nursoy, Mustafa Atilla; ÇAKIR, ERKAN; BİLGİN, MEHMET; YAZAN, HAKAN; NURSOY, MUSTAFA ATİLLAPublication inhaler allerjen duyarlılığı olan astım hastalarında astım öngörü indeksinin dğerlendirilmesi(2018-04-12T00:00:00Z) Yazan, Hakan; Al Shadfan, Lina Muhammed; Çakır, Erkan; Nursoy, Mustafa Atilla; Özkaya, Emin; YAZAN, HAKAN; ÇAKIR, ERKAN; NURSOY, MUSTAFA ATİLLA; ÖZKAYA, EMİNPublication Çocuklarda aeresol tedavi uygulamaları(2019-01-01T00:00:00Z) Yazan, Hakan; Çakır, Erkan; YAZAN, HAKAN; ÇAKIR, ERKANPublication Post-intubation subglottic stenosis in children: analysis of clinical features and ris factors(2018-06-16T00:00:00Z) Yazan, Hakan; Çakır, Erkan; Kılınç, Ayşe Ayzıt; Çalım, Ömer Faruk; Uzuner, Selçuk; Özturan, Orhan; YAZAN, HAKAN; ÇALIM, ÖMER FARUK; UZUNER, SELÇUK; ÖZTURAN, ORHANPublication Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators(2024-01-01) Nayır Büyükşahin H.; EMİRALİOĞLU ORDUKAYA N.; Yalçın E.; Şen V.; Selimoğlu Şen H.; Arslan H.; Başkan A. K.; Çakır F. B.; Koray C. F.; Yılmaz A. İ.; et al.; ÇAKIR, FATMA BETÜL; OGUN, HAMZA; YAZAN, HAKAN; ÇAKIR, ERKANIntroduction: Cystic fibrosis transmembrane conductance regulator (CFTR) modulator drugs target the underlying defect and improve CFTR function. They are a part of standard care in many countries, but not all patients are eligible for these drugs due to age and genotype. Here, we aimed to determine the characteristics of non-eligible patients for CFTR modulators in the CF registry of Turkey (CFRT) to highlight their clinical needs. Methods: This retrospective cohort study included CF patient data from the CFRT in 2021. The decision of eligibility for the CFTR modulator was determined according to the ‘Vertex treatment-Finder\" on the Vertex® website. Demographic and clinical characteristics of patients were compared between eligible (group 1) and ineligible (group 2) groups for CFTR modulators. Results: Among the study population (N = 1527), 873 (57.2%) were in group 1 and 654 (42.8%) were in group 2. There was no statistical difference between groups regarding sex, meconium ileus history, diagnoses via newborn screening, FEV1 z-score, CF-associated complications, organ transplant history, and death. Patients in group 2 had a higher incidence of pancreatic insufficiency (87.7% vs. 83.2%, p =.010), lower median height z-scores (−0.87 vs. −0.55, p <.001), lower median body mass index z-scores (−0.65 vs. −0.50, p <.001), longer days receiving antibiotics due to pulmonary exacerbation (0 [interquartile range, IQR: 0–2] vs. 0 [IQR: 0–7], p = 0.001), and more non-invasive ventilation support (2.6% vs. 0.9%, p = 0.008) than patients in group 1. Conclusion: The ineligible group had worse clinical outcomes than the eligible group. This highlights their need for life-changing drugs to improve clinical outcomes.Publication pediyatri(2020-01-01T00:00:00Z) Çakır, Erkan; Yazan, Hakan; ÇAKIR, ERKAN; YAZAN, HAKANPublication infantil crohn hastalığında infliximab tedavisine rağmen akciğer tututlumu(2018-09-12T00:00:00Z) Çakır, Erkan; Yazan, Hakan; Al Shadfan, Lin Amuhammed; ÇAKIR, ERKAN; YAZAN, HAKANPublication Oral Hygiene, Oral Health and Periodontal Health in Non-Cystic Fibrosis Bronchiectasis Patients(2020-08-01T00:00:00Z) Kahraman, Fedza Ustabas; ÖZALP, ŞERİFE; Yazan, Hakan; ÇAKIR, Erkan; ÖZDEMİR, ŞERİFE; YAZAN, HAKAN; ÇAKIR, ERKANINTRODUCTION: The aim of the study was to compare the parameters related to oral hygiene, oral and periodontal health of children with and without non-cystic fibrosis bronchiectasis (non-CF BE).Publication Pseudo bartter sendromu: Ulusal kistik fibrozis kayıt sisteminde saptanan en sık komplikasyon.(2019-04-11T00:00:00Z) Eyüboğlu, Tuğba Şişmanlar; Doğru Ersöz, Deniz; Çakır, Erkan; Yazan, Hakan; ÇAKIR, ERKAN; YAZAN, HAKAN